髂动脉导管在复杂血管腔内主动脉修复术中仍安全
该单中心回顾性研究分析2006至2016年137例因血管腔内主动脉修复术行髂动脉导管(IC)置入的患者,共144次IC置入。结果显示30天相关死亡率为2.1%,计划性或分期IC并发症较少,非计划IC与更高并发症率相关。结论认为IC对髂动脉入路困难的高危患者是安全可行的选择。
要点
- IC置入后30天相关死亡率为2.1%,围术期并发症可控。
- 分期IC较同期IC术后并发症、呼吸衰竭、感染及脑血管意外更少。
- 非计划IC与更高估计失血量、输血量及总体并发症率相关。
核心结论
- IC是髂动脉入路困难的复杂血管腔内主动脉修复术高危患者的安全可行选择。
- IC最好以计划性或分期方式实施(如可行)。
研究设计与样本
- 单中心回顾性分析2006至2016年因血管腔内主动脉修复术行IC置入的患者。
- 共137例患者,144次IC置入(9例双侧),包括计划与非计划、分期与同期IC。
主要发现
- 30天相关死亡率为2.1%(n=3)。
- 围术期并发症包括重返手术室5例(5.6%)、心肌梗死4例(2.8%)、呼吸衰竭5例(3.5%)、伤口并发症12例(8.3%)、肾损伤7例(4.9%),其中3例进展至透析(2.1%)。
- 分期IC术后并发症(P<.001)、呼吸衰竭(P<.05)、感染并发症(P<.05)及术后脑血管意外(P<.05)更少。
- 非计划IC与更高估计失血量(P<.001)、手术室输血量(P<.001)及总体并发症率(P<.05)相关。
- 女性(P<.05)、术前慢性肾病(P<.05)及同期IC(P<.001)与更高总体并发症率相关。
关键数值与推荐
- IC置入用于适应20F至24F鞘管尺寸共131例(91.0%)。
- 非计划IC的相关因素为髂动脉破裂及术前评估尺寸合适但无法推进内移植物(P<.001)。
临床怎么用
- 对髂动脉入路困难的复杂血管腔内主动脉修复术高危患者,可考虑计划性或分期IC置入。
- 应尽量规划IC以避免非计划置入,因其与更高失血量、输血量及并发症率相关。
局限性
- 单中心回顾性设计可能限制结果外推。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Iliac conduits (ICs) are used for challenging iliac access during endovascular aortic aneurysm repair (EVAR) with contradictory reports of safety and increased surgical complications, morbidity, and mortality in national database reviews. The objective of this study was to examine outcomes related to IC placement before or concomitant with EVAR at a high-volume single center. METHODS: A retrospective analysis of patients who underwent IC placement for endovascular aortic repair from 2006 to 2016 was conducted. Planned and unplanned, as well as staged and concomitant IC for EVAR, thoracic EVAR, and fenestrated/branched EVAR were included. Categorical factors were described using frequencies and percentages. Continuous measures were summarized in comparative tables. Comparisons between the planned and unplanned groups, concomitant and staged groups, and between those with and without a postoperative event were performed using Pearson χ2 tests, two-sample t-tests, and Wilcoxon rank-sum tests. RESULTS: A total of 137 patients underwent IC placement, of which 9 were bilateral procedures, for a total of 144 IC placements. IC placement was necessary in 14 EVARs (9.7%), 38 thoracic EVARs (26.4%), and 92 fenestrated/branched EVARs (63.9%). The 30-day related mortality was 2.1% (n = 3). Perioperative morbidities included return to the operating room in five patients (5.6%) for bleeding (n = 4) and graft thrombosis (n = 1), 4 myocardial infarctions (2.8%), 5 episodes of respiratory failure (3.5%), 12 wound complications (8.3%), and 7 renal injuries (4.9%), of which 3 had progression to dialysis (2.1%). Other complications included return to the operating room for endoleak reintervention (n = 3) and late graft infection (n = 1 [0.7%]). There were 112 ICs (77.8%) planned and 65 (45.1%) were staged. Staged ICs were less likely to have postoperative complications (P < .001), respiratory failure (P < .05), infectious complications (P < .05), and postoperative cerebrovascular accidents (P < .05). ICs were done to accommodate 20F to 24F sheath sizes in 131 instances (91.0%). Factors associated with unplanned IC placement were iliac rupture and an inability to advance the endograft in arteries deemed size-appropriate preoperatively (P < .001). Unplanned ICs were associated with higher estimated blood loss (P < .001), operating room transfusion volume (P < .001), and overall complication rates (P < .05). Women (P < .05), preoperative chronic kidney disease (P < .05), and concomitant IC placement (P < .001) were associated with higher overall complication rates. Operative time, estimated blood loss, and operating room transfusion volume were associated with increased rate of complications in comparison between all subgroups (P < .05). CONCLUSIONS: ICs are a safe and viable option for high-risk patients with challenging iliac artery access for EVVAR. ICs are best performed in a planned fashion or in a staged manner, when feasible.
引用
- Rowse JW, Morrow K, Bena JF, et al. Iliac conduits remain safe in complex endovascular aortic repair. J Vasc Surg. 2018. PMID: 30598354. doi:10.1016/j.jvs.2018.10.099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。